Lv51
1050 积分 2023-10-13 加入
Efficacy and Safety of Elafibranor in Primary Biliary Cholangitis
3个月前
已完结
PPAR Agonists in Primary Biliary Cholangitis
3个月前
已完结
Tongue Necrosis in Giant-Cell Arteritis
9个月前
已完结
Protein kinase C (PKC) isoforms in cancer, tumor promotion and tumor suppression
10个月前
已完结
S1P-S1PR3-RAS promotes the progression of S1PR3hi TAL1+ T-cell acute lymphoblastic leukemia that can be effectively inhibited by an S1PR3 antagonist
10个月前
已完结
HATS off to KAT6A/B inhibitors: A new way to target estrogen-receptor-positive breast cancer
10个月前
已完结
Potentials of PKC in Cancer Progression and Anticancer Drug Development
10个月前
已完结
Discovery of Darovasertib (NVP-LXS196), a Pan-PKC Inhibitor for the Treatment of Metastatic Uveal Melanoma
10个月前
已完结
Novel protein kinase cAMP-Activated Catalytic Subunit Alpha (PRKACA) inhibitor shows anti-tumor activity in a fibrolamellar hepatocellular carcinoma model
10个月前
已完结
Novel protein kinase cAMP-Activated Catalytic Subunit Alpha (PRKACA) inhibitor shows anti-tumor activity in a fibrolamellar hepatocellular carcinoma model
10个月前
已完结
皖公网安备34019202002308
